CBRE GROUP INC - A (CBRE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CBRE • US12504L1098

173.95 USD
+2.97 (+1.74%)
Last: Feb 10, 2026, 11:01 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, CBRE scores 5 out of 10 in our fundamental rating. CBRE was compared to 63 industry peers in the Real Estate Management & Development industry. CBRE has only an average score on both its financial health and profitability. CBRE is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, CBRE could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CBRE had positive earnings in the past year.
  • CBRE had a positive operating cash flow in the past year.
  • CBRE had positive earnings in each of the past 5 years.
  • CBRE had a positive operating cash flow in each of the past 5 years.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • With an excellent Return On Assets value of 4.30%, CBRE belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • CBRE's Return On Equity of 14.39% is amongst the best of the industry. CBRE outperforms 95.24% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.76%, CBRE belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CBRE is above the industry average of 5.41%.
Industry RankSector Rank
ROA 4.3%
ROE 14.39%
ROIC 6.76%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.12%, CBRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CBRE has declined.
  • Looking at the Operating Margin, with a value of 4.18%, CBRE is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
  • CBRE's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 19.22%, CBRE perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
  • CBRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.18%
PM (TTM) 3.12%
GM 19.22%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CBRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CBRE has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CBRE has less shares outstanding
  • Compared to 1 year ago, CBRE has a worse debt to assets ratio.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 3.63 indicates that CBRE is not in any danger for bankruptcy at the moment.
  • CBRE has a Altman-Z score of 3.63. This is in the better half of the industry: CBRE outperforms 73.02% of its industry peers.
  • CBRE has a debt to FCF ratio of 5.36. This is a neutral value as CBRE would need 5.36 years to pay back of all of its debts.
  • CBRE's Debt to FCF ratio of 5.36 is fine compared to the rest of the industry. CBRE outperforms 71.43% of its industry peers.
  • CBRE has a Debt/Equity ratio of 0.84. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
  • CBRE has a Debt to Equity ratio (0.84) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 5.36
Altman-Z 3.63
ROIC/WACC0.77
WACC8.82%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that CBRE should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.13, CBRE is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
  • CBRE has a Quick Ratio of 1.13. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • CBRE's Quick ratio of 1.13 is on the low side compared to the rest of the industry. CBRE is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • CBRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.41%, which is quite impressive.
  • Measured over the past 5 years, CBRE shows a small growth in Earnings Per Share. The EPS has been growing by 6.61% on average per year.
  • Looking at the last year, CBRE shows a quite strong growth in Revenue. The Revenue has grown by 14.61% in the last year.
  • The Revenue has been growing by 8.40% on average over the past years. This is quite good.
EPS 1Y (TTM)43.41%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%34.17%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%13.52%

3.2 Future

  • Based on estimates for the next years, CBRE will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.98% on average per year.
  • The Revenue is expected to grow by 9.04% on average over the next years. This is quite good.
EPS Next Y26.31%
EPS Next 2Y21.32%
EPS Next 3Y19.54%
EPS Next 5Y17.98%
Revenue Next Year14.36%
Revenue Next 2Y12.03%
Revenue Next 3Y10.84%
Revenue Next 5Y9.04%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • CBRE is valuated quite expensively with a Price/Earnings ratio of 29.09.
  • CBRE's Price/Earnings ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 73.02% of the companies in the same industry.
  • CBRE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
  • A Price/Forward Earnings ratio of 23.13 indicates a rather expensive valuation of CBRE.
  • Based on the Price/Forward Earnings ratio, CBRE is valued cheaper than 82.54% of the companies in the same industry.
  • CBRE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.86.
Industry RankSector Rank
PE 29.09
Fwd PE 23.13
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CBRE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 68.25% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CBRE is valued a bit cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.98
EV/EBITDA 21.41
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CBRE may justify a higher PE ratio.
  • CBRE's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.11
PEG (5Y)4.4
EPS Next 2Y21.32%
EPS Next 3Y19.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBRE GROUP INC - A

NYSE:CBRE (2/10/2026, 11:01:04 AM)

173.95

+2.97 (+1.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-23
Earnings (Next)02-12
Inst Owners97.94%
Inst Owner Change-1.58%
Ins Owners0.51%
Ins Owner Change-0.65%
Market Cap51.77B
Revenue(TTM)39.33B
Net Income(TTM)1.23B
Analysts82
Price Target192.39 (10.6%)
Short Float %0.9%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.25%
Min EPS beat(2)7.92%
Max EPS beat(2)8.58%
EPS beat(4)4
Avg EPS beat(4)7.29%
Min EPS beat(4)2.25%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)8.93%
EPS beat(12)12
Avg EPS beat(12)8.14%
EPS beat(16)14
Avg EPS beat(16)8.73%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)1.13%
Revenue beat(4)1
Avg Revenue beat(4)-0.61%
Min Revenue beat(4)-1.96%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)-0.11%
Revenue beat(12)7
Avg Revenue beat(12)0.83%
Revenue beat(16)8
Avg Revenue beat(16)0.09%
PT rev (1m)1.21%
PT rev (3m)5.23%
EPS NQ rev (1m)-0.58%
EPS NQ rev (3m)-0.24%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.69%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 29.09
Fwd PE 23.13
P/S 1.32
P/FCF 37.98
P/OCF 30.85
P/B 6.07
P/tB N/A
EV/EBITDA 21.41
EPS(TTM)5.98
EY3.44%
EPS(NY)7.52
Fwd EY4.32%
FCF(TTM)4.58
FCFY2.63%
OCF(TTM)5.64
OCFY3.24%
SpS132.15
BVpS28.68
TBVpS-0.99
PEG (NY)1.11
PEG (5Y)4.4
Graham Number62.12
Profitability
Industry RankSector Rank
ROA 4.3%
ROE 14.39%
ROCE 9.44%
ROIC 6.76%
ROICexc 7.37%
ROICexgc 14.13%
OM 4.18%
PM (TTM) 3.12%
GM 19.22%
FCFM 3.47%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
ROICexc(3y)8.16%
ROICexc(5y)8.57%
ROICexgc(3y)18.67%
ROICexgc(5y)19.47%
ROCE(3y)9.51%
ROCE(5y)9.85%
ROICexgc growth 3Y-10.49%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y-6.39%
ROICexc growth 5Y-5.52%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 5.36
Debt/EBITDA 2.86
Cap/Depr 36.25%
Cap/Sales 0.8%
Interest Coverage 3.96
Cash Conversion 66.77%
Profit Quality 110.99%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 3.63
F-Score6
WACC8.82%
ROIC/WACC0.77
Cap/Depr(3y)45.67%
Cap/Depr(5y)46.01%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.91%
Profit Quality(3y)86.59%
Profit Quality(5y)117.01%
High Growth Momentum
Growth
EPS 1Y (TTM)43.41%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%34.17%
EPS Next Y26.31%
EPS Next 2Y21.32%
EPS Next 3Y19.54%
EPS Next 5Y17.98%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%13.52%
Revenue Next Year14.36%
Revenue Next 2Y12.03%
Revenue Next 3Y10.84%
Revenue Next 5Y9.04%
EBIT growth 1Y13.34%
EBIT growth 3Y-0.86%
EBIT growth 5Y2.79%
EBIT Next Year61.5%
EBIT Next 3Y26.91%
EBIT Next 5Y18.6%
FCF growth 1Y944.54%
FCF growth 3Y-13.36%
FCF growth 5Y8.54%
OCF growth 1Y280.59%
OCF growth 3Y-10.27%
OCF growth 5Y6.9%

CBRE GROUP INC - A / CBRE FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


What is the valuation status of CBRE GROUP INC - A (CBRE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


What is the profitability of CBRE stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for CBRE stock?

The Earnings per Share (EPS) of CBRE GROUP INC - A (CBRE) is expected to grow by 26.31% in the next year.